| Primary |
| Anaemia |
28.6% |
| Infertility |
28.6% |
| Gestational Diabetes |
14.3% |
| High Risk Pregnancy |
14.3% |
| Urinary Tract Infection |
14.3% |
|
| Maternal Drugs Affecting Foetus |
50.0% |
| Urethral Dilatation |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
43.6% |
| Drug Use For Unknown Indication |
15.1% |
| Bipolar I Disorder |
5.8% |
| Drug Exposure During Pregnancy |
5.2% |
| Cholelithiasis |
4.2% |
| Cholecystectomy |
3.9% |
| Influenza |
3.5% |
| Anaesthesia |
2.5% |
| Gastroenteritis |
2.1% |
| Vomiting |
2.0% |
| Abdominal Pain |
1.8% |
| Haemorrhoids |
1.7% |
| Pain |
1.6% |
| Pyrexia |
1.5% |
| Prophylaxis |
1.1% |
| Gastrointestinal Disorder |
1.0% |
| Poisoning Deliberate |
1.0% |
| Urinary Tract Infection |
0.9% |
| Diarrhoea |
0.8% |
| Anxiety |
0.7% |
|
| Toxic Epidermal Necrolysis |
15.3% |
| Stevens-johnson Syndrome |
9.2% |
| Grand Mal Convulsion |
7.1% |
| Toxic Skin Eruption |
7.1% |
| Cytolytic Hepatitis |
6.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.1% |
| Premature Baby |
5.1% |
| Renal Failure Acute |
5.1% |
| Leukopenia |
4.1% |
| Malaise |
4.1% |
| Urticaria |
4.1% |
| Acute Generalised Exanthematous Pustulosis |
3.1% |
| Agranulocytosis |
3.1% |
| Gamma-glutamyltransferase Increased |
3.1% |
| Hepatocellular Injury |
3.1% |
| Lung Disorder |
3.1% |
| Purpura |
3.1% |
| Rash |
3.1% |
| Septic Shock |
3.1% |
| Staphylococcal Infection |
3.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.8% |
| Product Used For Unknown Indication |
21.2% |
| Pain |
7.7% |
| Crohn's Disease |
6.7% |
| Hypertension |
4.9% |
| Hiv Infection |
4.8% |
| Abdominal Pain |
4.8% |
| Prophylaxis |
3.9% |
| Sarcoma |
3.4% |
| Anxiety |
2.6% |
| Nausea |
2.1% |
| Thrombosis Prophylaxis |
2.0% |
| Depression |
1.8% |
| Constipation |
1.7% |
| Pyrexia |
1.7% |
| Antiviral Treatment |
1.5% |
| Acute Myeloid Leukaemia |
1.4% |
| Insomnia |
1.4% |
| Colitis Ulcerative |
1.3% |
| Colorectal Cancer Metastatic |
1.3% |
|
| Thrombocytopenia |
12.1% |
| Vomiting |
10.7% |
| Renal Failure Acute |
10.0% |
| Cytolytic Hepatitis |
6.4% |
| Rhabdomyolysis |
5.0% |
| Sepsis |
5.0% |
| Weight Decreased |
5.0% |
| Neutropenia |
4.6% |
| Pyrexia |
4.3% |
| General Physical Health Deterioration |
3.9% |
| Subileus |
3.9% |
| Hyponatraemia |
3.6% |
| Pulmonary Embolism |
3.6% |
| Vertigo |
3.6% |
| Pancreatitis |
3.2% |
| Rectal Haemorrhage |
3.2% |
| Toxoplasmosis |
3.2% |
| Cholestasis |
2.9% |
| Lung Disorder |
2.9% |
| Urinary Retention |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Pancreatitis Acute |
100.0% |
|
